Abstract
Left ventricular hypertrabeculation / noncompaction (LVHT) is in the majority of the cases associated with hereditary cardiac or skeletal muscle disease or with chromosomal abnormalities. Depending on the study more than two thirds of the LVHT patients also present with a neuromuscular disorder (NMD). NMDs most frequently associated with LVHT are the Barth syndrome, mitochondrial disorders, zaspopathy, and myotonic dystrophies. NMDs only occasionally presenting with LVHT are the dystrobrevinopathy, laminopathies, dystrophinopathies, myoadenylat-deaminase deficiency, hereditary inclusion body myositis and the hereditary neuropathy CMT1A. A causal relation between NMDs and LVHT is likely, although the exact relationship and pathomechanic association remains elusive. The close pathogenetic relation is supported by the fact that the phenomenon of acquired LVHT occurs predominantly in NMDs. Consequent referral of LVHT patients to the neurologist, consequent referral of NMD patients to the cardiologist, and family investigations may help to elucidate unsolved issues concerning the pathogenesis, course and prognosis of LVHT.
Keywords: Hypertrabeculation, spongy myocardium, echocardiography, systolic function, embolism, stroke, myopathy, neuropathy, peripheral nervous system, Left ventricular hypertrabeculation/noncompaction (LVHT), neuromuscular disorder, zaspopathy, myotonic dystrophies, dystrobrevinopathy, laminopathies, dystrophinopathies, myoadenylat-deaminase deficiency, Becker muscular dystrophy, mitochondrial disorder, Duchenne muscular dystrophy, myoadenylate-deaminase, Laminopathy, Myotonic dystrophy type 2, cyclic neutropenia, methyl-glutaconic acid, hypocholesterolemia, tafazzine (TAZ), glycerolipid trans-ferases, tetralinoleoyl-cardiolipin, lactacidosis, hyperammonaemia, hypoglyce-mia, malignant arrhythmias, nail-patella syndrome, leucodystrophy, desmin, B-crystallin, myotillin gene, pseudomyotonic discharges, ophthalmoplegia, dystrophin-glycoprotein complex, Transthoracic echocardiography, sinusbradycardia, Inclusion body Myopathy, myalgias, polyarthralgias, hyper-CK-emia, hypoesthesias, dysesthesias
Current Pharmaceutical Design
Title: Neuromuscular Disorders in Left Ventricular Hypertrabeculation/Noncompaction
Volume: 16 Issue: 26
Author(s): Josef Finsterer, Claudia Stollberger and Giovanni Fazio
Affiliation:
Keywords: Hypertrabeculation, spongy myocardium, echocardiography, systolic function, embolism, stroke, myopathy, neuropathy, peripheral nervous system, Left ventricular hypertrabeculation/noncompaction (LVHT), neuromuscular disorder, zaspopathy, myotonic dystrophies, dystrobrevinopathy, laminopathies, dystrophinopathies, myoadenylat-deaminase deficiency, Becker muscular dystrophy, mitochondrial disorder, Duchenne muscular dystrophy, myoadenylate-deaminase, Laminopathy, Myotonic dystrophy type 2, cyclic neutropenia, methyl-glutaconic acid, hypocholesterolemia, tafazzine (TAZ), glycerolipid trans-ferases, tetralinoleoyl-cardiolipin, lactacidosis, hyperammonaemia, hypoglyce-mia, malignant arrhythmias, nail-patella syndrome, leucodystrophy, desmin, B-crystallin, myotillin gene, pseudomyotonic discharges, ophthalmoplegia, dystrophin-glycoprotein complex, Transthoracic echocardiography, sinusbradycardia, Inclusion body Myopathy, myalgias, polyarthralgias, hyper-CK-emia, hypoesthesias, dysesthesias
Abstract: Left ventricular hypertrabeculation / noncompaction (LVHT) is in the majority of the cases associated with hereditary cardiac or skeletal muscle disease or with chromosomal abnormalities. Depending on the study more than two thirds of the LVHT patients also present with a neuromuscular disorder (NMD). NMDs most frequently associated with LVHT are the Barth syndrome, mitochondrial disorders, zaspopathy, and myotonic dystrophies. NMDs only occasionally presenting with LVHT are the dystrobrevinopathy, laminopathies, dystrophinopathies, myoadenylat-deaminase deficiency, hereditary inclusion body myositis and the hereditary neuropathy CMT1A. A causal relation between NMDs and LVHT is likely, although the exact relationship and pathomechanic association remains elusive. The close pathogenetic relation is supported by the fact that the phenomenon of acquired LVHT occurs predominantly in NMDs. Consequent referral of LVHT patients to the neurologist, consequent referral of NMD patients to the cardiologist, and family investigations may help to elucidate unsolved issues concerning the pathogenesis, course and prognosis of LVHT.
Export Options
About this article
Cite this article as:
Finsterer Josef, Stollberger Claudia and Fazio Giovanni, Neuromuscular Disorders in Left Ventricular Hypertrabeculation/Noncompaction, Current Pharmaceutical Design 2010; 16 (26) . https://dx.doi.org/10.2174/138161210793176437
DOI https://dx.doi.org/10.2174/138161210793176437 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
G Protein-Coupled Receptors: Target-Based In Silico Screening
Current Pharmaceutical Design Synthetic Approaches to the 2006 New Drugs
Mini-Reviews in Medicinal Chemistry Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms
Endocrine, Metabolic & Immune Disorders - Drug Targets Modified LDL Immune Complexes and Cardiovascular Disease
Current Medicinal Chemistry Depression in Coronary Heart Disease Patients: Etiological and Screening Issues
Current Psychiatry Reviews Characterization and Management of Cutaneous Side Effects Related to the Immunosuppressive Treatment in Solid Organ Recipients
Current Drug Targets Disulfiram's Anticancer Activity: Evidence and Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Turning the Clock Ahead: Potential Preclinical and Clinical Neuropharmacological Targets for Alcohol Dependence
Current Pharmaceutical Design Cancer-Homing Toxins
Current Pharmaceutical Design Boronated DNA-Binding Compounds as Potential Agents for Boron Neutron Capture Therapy
Mini-Reviews in Medicinal Chemistry Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis
Current Rheumatology Reviews Surgical Treatment of the Sleep Apnea Syndrome in the Twenty-First Century
Current Respiratory Medicine Reviews Protein Lysine Methyltransferases Inhibitors
Current Medicinal Chemistry Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Protein-Tyrosine Kinases and Adaptor Proteins in FcεRI-Mediated Signaling in Mast Cells
Current Molecular Medicine Gene Therapy in Plastic and Reconstructive Surgery
Current Gene Therapy Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Notch Signaling in Leukemias and Lymphomas
Current Molecular Medicine NorA, Tet(K), MepA, and MsrA Efflux Pumps in <i>Staphylococcus aureus</i>, their Inhibitors and 1,8-Naphthyridine Sulfonamides
Current Pharmaceutical Design Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma
Current Cancer Drug Targets